Decoding tumor heterogeneity: A spatially informed pan-cancer analysis of the tumor microenvironment
Francesca Lodi(VIB-KU Leuven Center for Cancer Biology), Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Jean‐Christophe Marine(VIB-KU Leuven Center for Cancer Biology), Amelie Franken(VIB-KU Leuven Center for Cancer Biology), Sarah Cappuyns(KU Leuven), Gabriele Bergers(VIB-KU Leuven Center for Cancer Biology), Gino Philips(VIB-KU Leuven Center for Cancer Biology), Liselore Loverix(VIB-KU Leuven Center for Cancer Biology), Sabine Tejpar(KU Leuven), Lucas F. Maciel(VIB-KU Leuven Center for Cancer Biology), Michel Bila(Universitair Ziekenhuis Leuven), Machteld Keupers(KU Leuven), Frederik De Smet(VIB-KU Leuven Center for Cancer Biology), Tom Venken(VIB-KU Leuven Center for Cancer Biology), Joanna Poźniak(VIB-KU Leuven Center for Cancer Biology), Jun Qian(Women's Hospital, School of Medicine, Zhejiang University), Sam Vanmassenhove(VIB-KU Leuven Center for Cancer Biology), Pierre Van Mol(KU Leuven), Jeroen Dekervel(Universitair Ziekenhuis Leuven), Hanne Vos(KU Leuven), Elena Donders(VIB-KU Leuven Center for Cancer Biology), Yiduo Zhou(Women's Hospital, School of Medicine, Zhejiang University), Siel Olbrecht(The European Academy of Gynaecological Surgery), Els Wauters(KU Leuven), Toon Van Gorp, Bram Boeckx(VIB-KU Leuven Center for Cancer Biology), Thomas Van Brussel(VIB-KU Leuven Center for Cancer Biology), Luuk Harbers(Science for Life Laboratory), Frederik Peeters, Duojiao Chen(Indiana University School of Medicine), Ayse Bassez(Vlaams Instituut voor Biotechnologie), Rogier Schepers(VIB-KU Leuven Center for Cancer Biology), Paul M. Clément(Universitair Ziekenhuis Leuven), Ann Smeets(KU Leuven), Oliver Bechter(Universitair Ziekenhuis Leuven)
Cited by 7
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
|Cancer Cell|2009|2.3k
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
|Cancer Cell|2005|1.6k
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k